AIM ImmunoTech
AIM
#10474
Rank
A$5.87 M
Marketcap
A$2.06
Share price
-5.52%
Change (1 day)
-94.04%
Change (1 year)

Earnings for AIM ImmunoTech (AIM)

Earnings in 2025 (TTM): -A$25.13 Million

According to AIM ImmunoTech 's latest financial reports the company's current earnings are A$0.12 Million. In 2024 the company made an earning of -A$26.03 Million, an increase over its 2023 earnings that were of -A$43.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AIM ImmunoTech from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$25.13 Million-3.46%
2024 -A$26.03 Million-40.2%
2023 -A$43.53 Million48.94%
2022 -A$29.23 Million1.66%
2021 -A$28.75 Million32.66%
2020 -A$21.67 Million51.18%
2019 -A$14.34 Million-2.81%
2018 -A$14.75 Million18.82%
2017 -A$12.42 Million10.09%
2016 -A$11.28 Million-50.74%
2015 -A$22.89 Million-12.72%
2014 -A$26.23 Million7.55%
2013 -A$24.39 Million-6.51%
2012 -A$26.08 Million21.22%
2011 -A$21.52 Million-7.56%
2010 -A$23.28 Million16.76%
2009 -A$19.94 Million3.54%
2008 -A$19.26 Million-33.58%
2007 -A$28.99 Million3.18%
2006 -A$28.1 Million89.3%
2005 -A$14.85 Million-9.31%
2004 -A$16.37 Million50.17%
2003 -A$10.9 Million9.55%
2002 -A$9.95 Million-24.79%
2001 -A$13.23 Million-2.66%
2000 -A$13.59 Million-6.78%
1999 -A$14.58 Million40.58%
1998 -A$10.37 Million6.15%
1997 -A$9.77 Million41.3%
1996 -A$6.92 Million360%
1995 -A$1.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.29 Million 12.31%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 886.51%๐Ÿ‡บ๐Ÿ‡ธ USA